← Peptide Library
Research GradeWeight Management & Metabolic
Semaglutide
5 mg
Long-acting GLP-1 receptor agonist for glycemic research.
Overview
Semaglutide is a long-acting GLP-1 analogue engineered with fatty-acid side-chain modification for extended half-life in research applications.
Mechanism of Action
Activates GLP-1 receptors on pancreatic β-cells to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying. Central receptors influence appetite-regulating circuits.
Research Findings
Semaglutide Once Weekly
Lancet, 2018
Foundational pharmacology and metabolic outcomes.
Potential Research Applications
- Glycemic control models
- Appetite regulation research